[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes that the regulatory review period for Baxters Obizur is 4,21...[ Price : $8.95]
Federal Register notice: FDA makes available a new draft guidance for industry on generic methylphenidate hydrochloride oral exten...[ Price : $8.95]
FDA determines for patent extension purposes that the regulatory review period for Baxters Obizur is 4,216 days.[ Price : $8.95]
FDA approves Janssen Biotechs Simponi Aria (golimumab) for treating adults with active psoriatic arthritis and active ankylosing s...[ Price : $8.95]
FDA approves a GlaxoSmithKline BLA for its Shingrix (zoster vaccine recombinant, adjuvanted) for preventing shingles (herpes zoste...[ Price : $8.95]
Octapharma USA withdraws two lots of Octagam 10% [immune globulin intravenous (human)] liquid preparation] that is labeled with lo...[ Price : $8.95]
FDA issues a Warning Letter to Magellan Diagnostics for modifying versions of two of its blood lead testing systems without the ag...[ Price : $8.95]
SCA Pharmaceuticals recalls all lots of several injectable products because there is a potential for them to contain microbial con...